Literature DB >> 22815149

The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.

Takehisa Hebishima1, Eiji Yuba, Kenji Kono, Shin-Nosuke Takeshima, Yoshihiro Ito, Yoko Aida.   

Abstract

We examined the ability of a novel liposome, surface modified by 3-methyl-glutarylated hyperbranched poly(glycidol) (MGlu-HPG), to enhance antigen-specific immunity in vitro and in vivo and to function as a vaccine carrier. Murine bone marrow-derived dendritic cells took up ovalbumin (OVA) encapsulated in MGlu-HPG-modified liposomes more effectively than free OVA or OVA encapsulated in unmodified liposomes. Immunization of mice with OVA-containing MGlu-HPG-modified liposomes induced antigen-specific splenocyte proliferation and production of gamma interferon (IFN-γ) more strongly than did immunization with free OVA or OVA encapsulated in unmodified liposomes. The immune responses induced by OVA encapsulated in MGlu-HPG-modified liposomes were significantly suppressed by addition of anti-major histocompatibility complex (MHC) class I and class II monoclonal antibodies, indicating the involvement of antigen presentation via MHC class I and II. Furthermore, delayed-type hypersensitivity responses and OVA-specific antibodies were induced more effectively in mice immunized with OVA encapsulated by MGlu-HPG-modified liposomes than with unencapsulated OVA or OVA encapsulated in unmodified liposomes. These results suggested that MGlu-HPG-modified liposomes effectively induced both cell-mediated and humoral immune responses. Collectively, this study is the first to demonstrate the induction of both cell-mediated and humoral immune responses in vivo by MGlu-HPG-modified liposomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815149      PMCID: PMC3428382          DOI: 10.1128/CVI.00273-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

Review 1.  New horizons in adjuvants for vaccine development.

Authors:  Steven G Reed; Sylvie Bertholet; Rhea N Coler; Martin Friede
Journal:  Trends Immunol       Date:  2008-12-06       Impact factor: 16.687

2.  Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes.

Authors:  Eiji Yuba; Chie Kojima; Naoki Sakaguchi; Atsushi Harada; Kazunori Koiwai; Kenji Kono
Journal:  J Control Release       Date:  2008-05-16       Impact factor: 9.776

3.  Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity.

Authors:  A Chauhan; Z Swaleha; N Ahmad; M Farazuddin; A Vasco; M Abida; Owais Mohammad
Journal:  Vaccine       Date:  2011-06-07       Impact factor: 3.641

4.  Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes.

Authors:  Eiji Yuba; Atsushi Harada; Yuichi Sakanishi; Kenji Kono
Journal:  J Control Release       Date:  2010-03-04       Impact factor: 9.776

5.  Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups.

Authors:  K Kono; K Zenitani; T Takagishi
Journal:  Biochim Biophys Acta       Date:  1994-07-13

6.  Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.

Authors:  Takashi Nakamura; Rumiko Moriguchi; Kentaro Kogure; Nilabh Shastri; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2008-06-17       Impact factor: 11.454

7.  Sperm membrane lipid liposomes can evoke an effective immune response against encapsulated antigen in BALB/c mice.

Authors:  S M Atif; N Salam; N Ahmad; I M Hasan; H S Jamal; A Sudhanshu; V Azevedo; M Owais
Journal:  Vaccine       Date:  2008-10-01       Impact factor: 3.641

8.  Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH.

Authors:  Naoki Sakaguchi; Chie Kojima; Atsushi Harada; Kenji Kono
Journal:  Bioconjug Chem       Date:  2008-05       Impact factor: 4.774

9.  pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity.

Authors:  Eiji Yuba; Chie Kojima; Atsushi Harada; Shinobu Watarai; Kenji Kono
Journal:  Biomaterials       Date:  2009-10-21       Impact factor: 12.479

Review 10.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

Authors:  Maria Laura Immordino; Franco Dosio; Luigi Cattel
Journal:  Int J Nanomedicine       Date:  2006
View more
  3 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

Review 2.  The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.

Authors:  Roberto Nisini; Noemi Poerio; Sabrina Mariotti; Federica De Santis; Maurizio Fraziano
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

3.  Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development.

Authors:  Sathish Sankar; Mageshbabu Ramamurthy; Subramanian Suganya; Balaji Nandagopal; Gopalan Sridharan
Journal:  Bioinformation       Date:  2018-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.